In April 2026, CureSHANK will convene the Phelan-McDermid Syndrome Drug Development Symposium 2026, a two-day, in-person meeting focused on accelerating therapeutic development for Phelan-McDermid syndrome (PMS).

 

Be part of a focused, high impact gathering dedicated to accelerating therapeutic development for PMS. Over two days at Cure in midtown Manhattan, NYC, leading experts in preclinical and clinical research will unpack the latest advances in translational science, clinical trial design, endpoint strategy, biomarker development, and more.

 

The event will culminate in a dynamic forum of drug developers and investors who will share real world insights, challenges, and opportunities in neurodevelopmental disease therapeutic innovation.

 

Please download and share the flyer below about the event: